General Information of the Compound
Compound ID
CP0428057
Compound Name
5-(2-oxo-1,3-dihydroindol-5-yl)-1H-pyrrole-2-carbonitrile
    Show/Hide
Synonyms
5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile
CHEMBL270909
    Show/Hide
Structure
Formula
C13H9N3O
Molecular Weight
223.235
Canonical SMILES
O=C1Cc2cc(ccc2N1)-c1ccc([nH]1)C#N
    Show/Hide
InChI
InChI=1S/C13H9N3O/c14-7-10-2-4-11(15-10)8-1-3-12-9(5-8)6-13(17)16-12/h1-5,15H,6H2,(H,16,17)
    Show/Hide
InChIKey
TVDRXBFEEAXOTN-UHFFFAOYSA-N
Physicochemical Property
logP
2.04798
Rotatable Bonds
1
Heavy Atom Count
17
Polar Areas
68.68
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
17

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24824217
SID: 49840448
ChEMBL ID
CHEMBL270909
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile )
Drug Name 5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile
Target(s)
Progesterone receptor (PGR)
Inhibitor